Tracheostomy Hemorrhage
Conditions
Brief summary
Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT. The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.
Interventions
DEVICETracheotomy
Tracheotomy in patients +/- antiplatelet therapy
Sponsors
Asklepios Neurological Clinic Bad Salzhausen
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patients who underwent Percutaneous Dilational Tracheostomy
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of bleeding during Percutaneous Dilational Tracheostomy (PDT) with and without antiplatelet therapy (AP). | 3 days | * bleeding (yes/no) * intervention (yes/no) * decrease (\>= 1 g/dl) of hemoglobin (yes/no) * number of blood transfusion(s) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| - Does the technique of PDT affect the bleeding rate? - How often are recognizable cartilage pin fractures in the context of a PDT? - Influence of AP and PDT technology on the frequency of need for a blood transfusion? | 14 days | cartilage pin fractures seen in endoscopy |
Countries
Germany
Contacts
Primary ContactDirk Bandorski, MD
Outcome results
None listed